Key Metrics
CiteScore 

2.4
Impact Factor 

< 5
SJR 

Q3Cardiology and Cardiovascular Medicine

SNIP 

0.43
Recommended pre-submission checks
Powered by 

Topics Covered on European Heart Journal, Supplement
European Heart Journal, Supplement Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European Heart Journal, Supplement ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in European Heart Journal, Supplement
Transcriptome analysis of changes associated with dexrazoxane or GDF15 pretreatment to protect against doxorubicin in human embryonic stem cell-derived cardiomyocytes
- 3 Aug 2026
- European Heart Journal Supplements
Feasibility and growth of a dedicated cardio-oncology service at a large victorian tertiary cardiac centre
- 3 Aug 2026
- European Heart Journal Supplements
Baseline cardiovascular assessment and incidence of major adverse cardiovascular events during immune checkpoint inhibitor therapy in a hungarian population
- 3 Aug 2026
- European Heart Journal Supplements
Angiotensin II unmasks immune checkpoint inhibitor-induced arrhythmias and conduction defects in mice
- 3 Aug 2026
- European Heart Journal Supplements
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in United Arab Emirates
- 14 Jul 2026
- European Heart Journal Supplements
May Measurement Month 2023: an analysis of blood pressure screening results from Oman
- 6 Jul 2026
- European Heart Journal Supplements
Transcriptome analysis of changes associated with dexrazoxane or GDF15 pretreatment to protect against doxorubicin in human embryonic stem cell-derived cardiomyocytes
- 3 Aug 2026
- European Heart Journal Supplements
Feasibility and growth of a dedicated cardio-oncology service at a large victorian tertiary cardiac centre
- 3 Aug 2026
- European Heart Journal Supplements
Baseline cardiovascular assessment and incidence of major adverse cardiovascular events during immune checkpoint inhibitor therapy in a hungarian population
- 3 Aug 2026
- European Heart Journal Supplements
Angiotensin II unmasks immune checkpoint inhibitor-induced arrhythmias and conduction defects in mice
- 3 Aug 2026
- European Heart Journal Supplements
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in United Arab Emirates
- 14 Jul 2026
- European Heart Journal Supplements
May Measurement Month 2023: an analysis of blood pressure screening results from Oman
- 6 Jul 2026
- European Heart Journal Supplements